Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer ; volume:10 ; number:1 ; day:4 ; month:5 ; year:2012 ; pages:1-9 ; date:12.2012
World journal of surgical oncology ; 10, Heft 1 (4.5.2012), 1-9, 12.2012
- Creator
-
Chiang, Kun-Chun
Yeh, Chun-Nan
Ueng, Shir-Hwa
Hsu, Jun-Te
Yeh, Ta-Sen
Jan, Yi-Yin
Hwang, Tsann-Long
Chen, Miin-Fu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1477-7819-10-77
- URN
-
urn:nbn:de:101:1-2021080711293144411770
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chiang, Kun-Chun
- Yeh, Chun-Nan
- Ueng, Shir-Hwa
- Hsu, Jun-Te
- Yeh, Ta-Sen
- Jan, Yi-Yin
- Hwang, Tsann-Long
- Chen, Miin-Fu
- SpringerLink (Online service)
Other Objects (12)
RON is not a prognostic marker for resectable pancreatic cancer
Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
Preoperative predictors for early recurrence of resectable pancreatic cancer
Surgery for elderly patients with resectable pancreatic cancer, a comparison with non-surgical treatments: a retrospective study outcomes of resectable pancreatic cancer
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
ACR Appropriateness Criteria® Resectable Rectal Cancer
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
A 25-gene classifier predicts overall survival in resectable pancreatic cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer
The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer
RON is not a prognostic marker for resectable pancreatic cancer
Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
Preoperative predictors for early recurrence of resectable pancreatic cancer
Surgery for elderly patients with resectable pancreatic cancer, a comparison with non-surgical treatments: a retrospective study outcomes of resectable pancreatic cancer
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
ACR Appropriateness Criteria® Resectable Rectal Cancer
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
A 25-gene classifier predicts overall survival in resectable pancreatic cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer
The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer
RON is not a prognostic marker for resectable pancreatic cancer
Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
Preoperative predictors for early recurrence of resectable pancreatic cancer
Surgery for elderly patients with resectable pancreatic cancer, a comparison with non-surgical treatments: a retrospective study outcomes of resectable pancreatic cancer
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
ACR Appropriateness Criteria® Resectable Rectal Cancer
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
A 25-gene classifier predicts overall survival in resectable pancreatic cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer